Multiple Sclerosis

Aug 04, 2020

MorphoSys, Incyte gets an early FDA nod for Monjuvi, an alternative to CAR-T for B-cell malignancies MorphoSys and Incyte announced the US FDA approval under accelerated approval for their treatment Monjuvi in combination with lenalidomide for adult patients with relapsed or refractory diffuse large B-cell lymp...

May 21, 2020

CanSino adds mRNA with Precision NanoSystems  CanSino Biologics is already evaluating a recombinant coronavirus vaccine in China. However, it is adding the mRNA to COVID-19 vaccine through a licensing agreement with Precision NanoSystems. The partners will work on an mRNA nanoparticle vaccine for COVID-1...

Jan 08, 2020

Cannabis sativa or Cannabis indica is commonly known as Medical marijuana or cannabis (cannabinoids) are prescribed by physicians to their patients, to treat diseases, conditions or to relieve pain or symptoms. As per the National Institute of Health, Marijuana or cannabis is used for the treatment of ailments for ...

May 30, 2019

Multiple Sclerosis Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system. In this disease, the body's own immune system produces cells and proteins (antibodies), which attack the fatty substance,myelin that protects the nerve fibres. So, 30 May 2019 is globally obser...

Apr 17, 2019

Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system, disrupting the transfer of information within, or between the brain and body. It causes the body’s immune system to produce cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsibl...

Apr 03, 2019

What exactly is Marijuana? In a layman language, Marijuana is the dried buds and leaves of a plant Cannabis sativa favored in warm, wild tropical climates. Earning names like pot, ganja, weed, hemp, hash, etc. it contains around 104 active cannabinoids (CBD). What they do is, they mimic the signal producing che...

Apr 02, 2019

Selumetinib gets the U.S. Breakthrough Therapy Designation Selumetinib- an investigational drug, for the treatment of pediatric patients aged three years and above suffering from symptomatic and/or progressive, inoperable neurofibromatosis type 1 (NF1), plexiform neurofibromas (PN)- a rare genetic condition, has...

Mar 28, 2019

Saama Technologies raises USD 40 Million to bolster AI Saama Technologies has got a hefty investment of USD 40million to accelerate its Artificial Intelligence and bolster its use in the branch of Life Sciences. This will help the California based data analytics company to innovate, curate and accelerate the cli...

Mar 07, 2019

Biogen to buy Nightstar for USD 800 Million Biogen known for its efforts in treatments of multiple sclerosis and spinal muscular atrophy wound up the deal to buy Nightstar. The deal will let Biogen have access to two experimental gene therapies for blindness-causing diseases helping Biogen’s pipeline. Pacira...

Nov 12, 2018

Could a virus be a treatment therapy? Confusing, isn't it? On the face value, it seems no; but on delving deeper, the confusion dissipates. There have been tireless efforts among a section of scientists to convert certain viruses through biotechnology techniques into anti-disease agents to infect and destroy cancer ...